Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
Awards
Outsourcing Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
Awards
Outsourcing Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Narcan
Manufacturing
Antheia seals 2nd series C funding close, hitting $175M
Biosynthesis specialist Antheia has topped off its series C funding with a second close, adding $24 million more to its haul.
Joseph Keenan
Jan 28, 2026 11:55am
JPM25: Recovering Emergent inks deal for opioid overdose spray
Jan 15, 2025 7:41pm
Emergent, ex-NFL star show how to tackle opioid overdoses
Jul 24, 2024 10:55am
Orexo's opioid overdose nasal spray is rejected again by FDA
Jul 17, 2024 10:47am
Amneal resolves opioid lawsuits with $272.5M settlement
May 6, 2024 11:00am
Emergent taps ex-NFL star to bring opioid message to tailgates
Oct 18, 2023 7:50am